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Ethnomedicinal surveys have documented the traditional use of Carallia brachiata (Lour.) Merill (Rhizophoraceae) 
leaves in the management of diabetes mellitus in the Northeastern region of India. This study screens the hydro-alcoholic 
extract (HAE) of C. brachiata leaves for antioxidant and antidiabetic activities. The HAE was prepared using ethanol:water 
(7:3) by cold maceration method. The antidiabetic activity of HAE was evaluated in vivo in streptozotocin-induced diabetic 
rats at the doses of 250 or 500 mg/kg body weight for 21 days. The extract was also evaluated for in vitro and in vivo 
antioxidant activity. Results revealed that HAE of C. brachiata leaves possesses good hypoglycemic activity in diabetic rats. 
The hypoglycemic activity of HAE was found significant as compared to normal rats. Results of antioxidant activity were 
found statistically significant compared to standard drugs, quercetin and gallic acid. Results indicated a possible role of the 
HAE of C. brachiata leaves as herbal antioxidants in the prevention and/ or treatment of oxidative stress-induced diabetes. 
Results suggested that antioxidant plant phenolics/ flavonoids might be responsible for the antidiabetic efficacy of HAE. 
Further research can be undertaken on the HAE of C. brachiata leaves for exploration of biochemical mechanisms of 
antidiabetic action with the isolation of bioactive flavonoids having antidiabetic potential. 
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Introduction 
Diabetes mellitus (or diabetes) is a metabolic disease 
characterized by hyperglycemia with abnormal 
carbohydrate, fat and protein metabolism resulting from 
defects in insulin secretion, insulin action or both. 
Hyperglycemia is usually accompanied by polyuria, 
polydipsia, weight loss, sometimes polyphagia, blurred 
vision and also susceptibility to infectious illness. The 
chronic hyperglycemic condition of diabetes may lead to 
several health complications including cardiovascular 
(cardiomyopathy), neurological (neuropathy), renal 
(nephropathy) and ocular (retinopathy)1. The prevalence 
of diabetes is increasing with the global rise of obesity 
and related lifestyle disorders. It has been estimated that 
there were 422 million adults living with diabetes 
mellitus in 2016, according to a global report by the 
World Health Organization (WHO). Type 2 diabetes  
has accounted for the majority (>85%) of diabetes 
worldwide2. 
Oxidative stress (OS) is believed to be the 
underlying cause of cellular injury, tissue damage or 
organ dysfunctions commonly associated with diabetic 
complications. OS refers to elevated intracellular levels 
of reactive oxygen species (ROS) that cause damage to 
biomolecules such as lipids, proteins and DNA. 
Cellular OS may be reduced to a considerable extent by 
the action of various antioxidant enzymes such as 
superoxide dismutase (SOD), catalase (CAT), 
glutathione reductase (GSH) and glutathione 
peroxidase (GPx)3. Besides antidiabetic drugs, 
antioxidant medications are also used to reduce the 
long term complications of diabetes mellitus. Despite 
the availability of hypoglycemic agents from synthetic 
sources, diabetes is still life-threatening because of 
limited therapeutic utility of existing drugs. Traditional 
medicines derived from plants play a significant  
role in the management of diabetes mellitus. WHO 
recommended the evaluation of traditional plant 
remedies used in the treatment of diabetes because they 
are effective with less or no toxicities as compared to 
synthetic oral hypoglycemic agents4,5. Many indigenous 
Indian medicinal plants have been found to be useful in 
the treatment of diabetes mellitus. 
Carallia brachiata (Lour.) Merill (Rhizophoraceae) 
is an evergreen tree distributed widely in India, Sri 
—————— 
*Correspondent author 
Email: kzaman71@dibru.ac.in 
Mob: 9435131755 
JUNEJO et al.: ANTIDIABETIC ACTIVITY OF CARALLIA BRACHIATA LOUR. LEAVES HYDRO-ALCOHOLIC EXTRACT 
 
 
19 
Lanka, Southern China, Thailand, and other parts of 
Southeast Asia. Fruits and seeds of the plant are used 
for edible purposes by different ethnic communities in 
various parts of India. The seed oil is used as a 
substitute for ghee6. Different parts of C. brachiata 
are used traditionally in the treatment of a variety of 
human disorders. Leaf decoction mixed with benzoin, 
turmeric and rice powder is used in the treatment of 
sapraemia7. The traditional uses of bark in the 
treatment of itching, cuts and wounds, oral ulcers, 
throat inflammation and stomatitis are all well 
documented8. According to Ayurveda, the Indian 
System of Medicine, leaves of C. brachiata are used 
as a medicine for diabetes mellitus9. Modern literature 
reported that ethyl acetate and methanol bark extracts 
of C. brachiata possess anti-inflammatory, wound 
healing and antimicrobial activities10. A group of 
proanthocyanidins (carallidin, mahuanin and para-
hydroxy benzoic acid) having antioxidant activities 
were reported from leaves and bark of this plant. 
Other phytoconstituents which include megastigmane 
diglycoside (3-hydroxy-5,6-epoxy-β-ionol-3-O-
βapiofuranosyl (1→6)-β-glucopyranoside), hygroline 
alkaloid, flavonoids and glyceroglycolipids have also 
been isolated from the leaves of C. Brachiata11. 
Ethnomedicinal survey documents the use of leaves 
infusion for the management of diabetes by the tribal 
people in Dibrugarh forest region of Dibrugarh 
district, Assam (India). There are no scientific reports 
in modern literature on the antidiabetic efficacy of  
C. brachiata leaves. The objective of the present 
study was to ascertain the scientific basis of using this 
particular plant species traditionally in the 
management of diabetes, using streptozotocin-induced 
diabetic rats. According to WHO guidelines, the 
extract of C. brachiata leaves was prepared using 
hydro-alcoholic solvent and evaluated for the 
antidiabetic activity. It has been reported that 
traditional medicinal plants having antidiabetic 
activity possess antioxidant potential in experimental 
animals. Moreover, since a biochemical relationship 
exists between diabetic hyperglycemia and cellular 
oxidative stress, the antidiabetic activity evaluation of 
the HAE of C. brachiata leaves was carried out along 
with the antioxidant activity study. 
 
Materials and Methods 
 
Chemicals 
All chemicals and reagents used in the study were 
of analytical grade and were procured from Rankem, 
Mumbai and Himedia Laboratories Ltd., Mumbai. 
Streptozotocin (STZ) was procured from Sigma-
Aldrich, Germany. Commercial reagent kits used  
for determination of biochemical parameters and 
enzymatic assays were purchased from SPAN 
Diagnostics Ltd., Surat (India). 
 
Plant material 
Fresh leaves of Carallia brachiata (Lour.) Merill 
(Rhizophoraceae) were collected from forest areas of 
Dibrugarh district, Assam (India) during the month of 
December 2014. The plant sample was identified  
and authenticated (BSI/ERC/2014/Plant identification/ 
360, dt. 26.08.2014) by Dr A. A. Mao, Scientist E, 
BSI, Eastern Regional Centre, Botanical Survey of 
India, Eastern Regional Centre, Shillong (India). A 
voucher specimen (DU/PSC/HRB/B-11/2014) of the 
identified plant species was deposited in the 
Herbarium of the Department of Pharmaceutical 
Sciences, Dibrugarh University, Dibrugarh.  
 
Preparation of HAE 
The air-dried leaves were coarsely powdered 
(Sieve no. 40) using a cutter mill, powdered leaves 
(50 g) were extracted using sufficient quantity  
(400 mL) of ethanol:water (7:3) mixture by cold 
maceration for 24 hours. The extraction was carried 
out successively thrice and the combined extract was 
then concentrated under reduced pressure to dryness 
in a rotary vacuum evaporator to obtain a thick 
semisolid-like paste. The crude extract was dried at -
40 °C in a lyophilizer and the dried extract (dark 
brown colour) so obtained was stored in a desiccator 
until further use. The % yield of the dried HAE was 
calculated per dry weight of powdered leaves.  
 
Test animals 
Healthy Wistar male albino rats (240-260 g) were 
maintained under standard environmental conditions 
(temperature 25±2 °C, relative humidity 50±5%)  
with a 12 h light/dark cycle. They were fed on with 
normal laboratory chow pellet diet and drinking  
water was given ad libitum. Animals were allowed to 
acclimatize for 7 days before commencement of the 
experiment. The animals were used with the approval 
(no. IAEC/DU/50 dt. 24.9.13) of the Institutional 
Animal Ethics Committee under guidelines set by the 
Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), 
New Delhi (India). 
 
Estimation of phenolic and flavonoid contents  
The total phenolic content of the HAE was 
evaluated following the Folin-Ciocalteu colourimetric 
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method12 and results were expressed as mg of gallic 
acid equivalent (GE) per g of dry weight of the 
extract. The total flavonoid content was estimated 
using the aluminium chloride colourimetric method13 
and results were expressed as mg of quercetin 
equivalent (QE) per g of dry weight of the extract. 
 
Estimation of total phenolic content (TPC) 
Briefly, 1 mL of HAE (1 mg/mL, in 90% ethanol) 
were made up to 3 mL with distilled water, mixed 
thoroughly with 0.5 mL of Folin-Ciocalteu reagent for 
5 minutes, followed by the addition of 2 mL of 20% 
aqueous (w/v) sodium carbonate. The mixture was 
allowed to stand for further 60 minutes in the dark, 
and absorbance was measured at 650 nm. The TPC 
was calculated from the calibration curve of gallic 
acid (20, 40, 60, 80, 100 µg/mL, 90% ethanol). 
Results were obtained as mean±SEM of three 
replicate studies. 
 
Estimation of total flavonoids contents (TFC) 
In brief, 0.5 mL of HAE (1 mg/mL, in 90% 
ethanol) were made up to 1 mL with ethanol, mixed 
with 4 mL of distilled water and then 0.3 mL of 5% 
NaNO2 solution, 0.5 mL of 10% AlCl3 solution were 
added after 5 minutes of incubation, and the mixture 
was allowed to stand for 5 minutes. To the above 
solution, 2 mL of 1 mol/L NaOH solution was added, 
and the final volume of the reaction mixture was 
made up to 10 mL with distilled water. The mixture 
was allowed to stand for 15 minutes, and absorbance 
was measured at 510 nm. The TFC was calculated 
from a calibration curve of quercetin (20, 40, 60, 80, 
100 µg/mL, 90% ethanol). Results were obtained as 
mean±SEM of three replicate studies. 
 
In vitro antioxidant activity 
The in vitro antioxidant activity of HAE was 
carried out by the following three assay methods in 
accordance with previously reported procedures with 
minor modifications. 
 
Superoxide radical scavenging activity 
Superoxide radical scavenging activity of HAE  
was determined by the nitro blue tetrazolium (NBT) 
reduction method. In this assay, the non-enzymatic 
phenazine methosulfate/nicotinamide adenine 
dinucleotide (PMS/NADH) system generates superoxide 
radicals, which reduce NBT to a purple colour 
formazan. The reaction mixture contained phosphate 
buffer (0.5 mL, 100 mM, pH 7.4), 1.0 mL of NADH 
(0.4 mM), 1.0 mL of NBT (0.156 mM), 0.1 mL of 
PMS (0.06 mM) and 3 mL of the HAE/standard drugs 
(quercetin and gallic acid) of various concentrations 
(50-250 µg/mL, in 90% ethanol). After incubation  
at 25 °C for 1 hour, the absorbance of the reaction 
mixture was measured at 560 nm against an 
appropriate blank to determine the quantity of 
formazan formed. 
 
Hydroxyl radical scavenging activity 
Hydroxyl radicals were generated by the Fenton 
reaction using Fe3+/ascorbate/EDTA/H2O2 system. 
The hydroxyl radical generated in the system attacks 
deoxyribose which eventually results in the formation 
of thiobarbituric acid (TBA) reacting substance 
(TBARS) which was estimated. The reaction mixture 
contained 0.1 mL of 2-deoxy-2-ribose (10 mM), 0.33 
mL of phosphate buffer (50 mM, pH 7.4), 0.1 mL of 
FeCl3 (0.1 mM), 0.1 mL ethylenediamine tetra-acetic 
acid (EDTA) (0.1 mM), 0.1 mL of H2O2 (2 mM), 0.1 
mL of ascorbic acid (1 mM) and 1.0 mL of various 
concentrations (50-250 µg/mL) of the HAE or 
standards (quercetin and gallic acid). After incubation 
for 45 minutes at 37 °C, 1.0 mL of 2.8% (v/v) TCA, 
and 1.0 mL of [thiobarbituric acid, TBA, 0.5% (v/v) 
in 0.025 mol/L NaOH solution containing 0.2% (w/v) 
of butylated hydroxyl anisole, BHA] were added in 
the reaction mixture, and the mixture was incubated at 
95 oC for 15 minutes to develop the pink chromogen. 
After cooling, the absorbance was measured at 532 
nm against an appropriate blank solution. 
 
Lipid peroxidation scavenging activity 
The Fe3+/ascorbic acid-dependent non-enzymatic 
lipid peroxidation in the liver extract was performed 
as follows. Reaction mixture (0.5 mL) containing rat 
liver homogenate (0.1 mL, 25% w/v) in Tris-HCl 
buffer (40 mM, pH 7.0), KCl (30 mM), FeCl3  
(0.16 mM) and ascorbic acid (0.06 mM) was 
incubated for 1 hour at 37 °C in the presence and 
absence of the HAE/ standard drugs (quercetin and 
gallic acid) at various concentrations (50-250 µg/mL). 
The lipid peroxide formed was measured by TBARS 
formation. For this incubation mixture, 0.4 mL was 
treated with sodium dodecyl sulphate (8.1%, 0.2 mL), 
TBA (0.8%, 1.5 mL) and acetic acid (20%, 1.5 mL, 
pH 3.5). The total volume was then made up to  
4.0 mL by adding distilled water and kept in a water 
bath at 100 °C for 1 hour. After cooling, 1 mL of 
distilled water and 5.0 mL of a mixture of n-butanol 
and pyridine (10:1 v/v) were added to the reaction 
mixture, shaken vigorously and centrifuged at  
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4000 rpm for 10 min. The butanol-pyridine layer was 
removed and its absorbance at 532 nm was measured 
to quantify TBARS.  
In all the three above methods, the percent 
inhibition of scavenging activity was calculated using 
the following equation (Eq. 1). 
 
Percent inhibition (%) = [(Acontrol - Atest)/ Acontrol] × 100 
 … (1) 
 
where, Acontrol is the absorbance of the control and Atest 
represents the absorbance of a test (HAE/ standard 
drug). 
Tests were performed in triplicate and values were 
obtained as mean ± SEM of three independent studies. 
Results were evaluated by comparing the percent 
inhibition of the activity of HAE with that of standard 
drugs. Quercetin and gallic acid were used as standard 
drugs. 
 
Acute oral toxicity study 
Over-night fasted rats were randomly divided into 
six groups of six animals each. Rats of different 
groups were administered with increasing doses (250, 
500, 1000, 2000, and 5000 mg/kg b.w.) of HAE. One 
group was maintained as normal control and was 
given vehicle alone. The animals were observed 
individually for the first hour for any gross 
behavioural changes including drowsiness, restlessness, 
writhing, convulsions and symptoms of toxicity and 
mortality if any, and then periodically for the next 
 24 hours, and then at every 24 hours for any signs  
of acute toxicity over a period of 14 days.  
The acute toxicity study was carried out as per OECD 
guideline 42514. 
 
Oral glucose tolerance (OGT) test 
This test was performed in overnight fasted normal 
rats according to the method reported by Junejo and 
co-workers15. Animals were divided into four groups 
of six each. Group I rats (normal control) were treated 
with vehicle alone. Group II and Group III rats  
were treated with HAE at 250 and 500 mg/kg b.w. 
doses, respectively. Group IV rats were treated  
with metformin hydrochloride (5 mg/kg b.w.). 
Carboxymethyl cellulose (CMC) solution (0.5% w/v 
in normal saline) was used as vehicle. Glucose 2 g/kg 
was fed orally 30 min after the administration of HAE 
and metformin hydrochloride. Blood was withdrawn 
from the tail vein at 0, 30, 60, 90 and 120 minutes, 
and glucose levels in blood were estimated by the 
GOD-POD method (Accu-Chek, Roche Diabetes 
Care India Pvt. Ltd., Mumbai, India). 
Hypoglycemic activity in streptozotocin-induced diabetic rats 
Diabetes was induced in overnight fasted animals 
by a single intraperitoneal (i.p.) injection of 
streptozotocin (STZ, 55 mg/kg b.w. in normal saline). 
The animals confirmed as diabetic (after 72 h of STZ 
injection) by the elevated plasma glucose levels (200-
300 mg/dL) was used for the experiment. The animals 
were divided randomly into five groups of six rats in 
each group. Group I rats served as normal control and 
were given vehicle (0.5% CMC w/v in normal saline) 
alone. Group II rats served as diabetic control and 
were administered with vehicle alone. Group III and 
IV were treated with HAE at 250 and 500 mg/kg b.w., 
respectively. Group V rats received the standard drug, 
metformin hydrochloride (5 mg/kg b.w.). Treatments 
were given orally using a canula once daily for a 
period of 21 days. Blood was collected from the tail 
vein each time for the determination of glucose levels 
on 0, 7, 14 and 21 days. Blood glucose levels were 
measured by the GOD-POD method16. 
 
Liver and kidney function tests 
The initial and final body weights were measured. 
Liver tissues were excised, blotted, weighed and 
stored at -70 °C for assay of glycogen content. Liver 
glycogen was estimated by the method of Carroll  
et al.17. Blood was collected by cardiac puncture in dry 
test tubes containing a mixture of potassium oxalate 
and sodium fluoride (1:3) and allowed to coagulate in 
ambient temperature for 30 minutes. The serum was 
separated by centrifugation (2000 rpm, 10 minutes) 
for estimation of various biochemical parameters. 
Serum insulin levels were measured by the microplate 
ELISA method using a commercial kit (SPAN 
Diagnostics Ltd.). Serum lipid profile was estimated 
using commercially available kits (SPAN Diagnostics 
kit). Triglycerides (TG) and total cholesterol (TC) 
were estimated by enzymatic methods, HDL (How 
density lipoprotein) cholesterol by phosphotungstate 
method and LDL (low density lipoprotein) cholesterol 
were calculated by Friedewald’s formula. 
Serum was used to estimate glutamate oxaloacetate 
transaminase (GOT) glutamate pyruvate transaminase 
(GPT) and alkaline phosphatase (ALP), total protein 
(TPR) and creatinine (CRTN). SGOT and SGPT were 
measured by UV kinetic method and ALKP was 
estimated by PNPP method. TPR was measured by 
Bradford Macro method, while CRTN was by picrate 
method. 
 
In vivo antioxidant activity 
On the 21st day, all the groups of animals were 
anaesthetized using diethyl ether, the liver was 
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dissected out, washed with normal saline and one part 
was preserved in 10% formalin for histopathological 
studies. The other part of the liver was homogenized 
by ice-chilled Tris-HCl buffer and used for 
activities/levels of superoxide dismutase (SOD), 
catalase, reduced glutathione (GSH), glutathione 
peroxidase (GPx), and malondialdehyde MDA. The 
malondialdehyde (MDA) production is a direct 
indicator of lipid peroxidation (LPO) process that was 
measured by TBA reaction using an ELISA reader  
(at 532 nm). 
 
Histopathological studies 
At the end of 21st day of treatment, the animals 
were fasted for 12 hours, anaesthetized using diethyl 
ether and sacrificed by cervical dislocation. Pancreas 
and liver were instantly dissected out, excised and 
rinsed in ice-cold saline solution. Tissues were 
processed as follows. A portion of pancreas/liver 
tissue was fixed in 10% formalin fixative solution for 
4 days. After fixation, tissues were dehydrated in 
ethanol (70-95%), cleared in xylene, and embedded in 
paraffin was, solid transverse sections of 4-5 µm 
thickness were obtained by using a rotary microtome. 
The sections were stained with hematoxylin-eosin and 
histopathological observations were carried out under 
a light microscope (40×). 
 
Statistical analysis 
Values are represented as mean±SEM of three 
replicate studies. Statistical analysis was performed 
using the IBM SPSS 19.0 statistical software package, 
for Windows. Statistical differences at 5% level of 
probability (P <0.05) between the groups were 
analyzed by one-way ANOVA followed by Student’s 
t-test5. 
 
Results 
 
TPC and TFC of HAE  
The TPC of HAE, calculated from the calibration 
curve of gallic acid (R2 =0.984), was 56.24±2.32 
gallic acid/g, and the total flavonoid content (R2 
=0.983), calculated from the calibration curve of 
quercetin was 45.52±2.65 quercetin/g. 
 
In vitro antioxidant activity 
 
Superoxide radical scavenging activity 
The HAE showed superoxide radical scavenging 
activity in a concentration-dependent manner. HAE, 
quercetin and gallic acid exhibited 78.34±0.56, 
82.38±0.54 and 86.37±83% of scavenging effect, 
respectively at the highest tested concentration of  
250 µg/mL. The inhibitory activity of HAE was found 
significant (P <0.05) compared to standard drugs, 
quercetin and gallic acid (Fig. 1). 
 
Hydroxyl radical scavenging activity 
The percent inhibition of hydroxyl radicals were 
84.72±0.27, 88.40±0.22 and 87.26±0.12% for HAE, 
quercetin and gallic acid, respectively at the 
concentration of 250 µg/mL. Results were statistically 
significant (P <0.05) as compared to standard drugs 
(Fig. 2). 
 
Lipid peroxidation scavenging activity 
LP induced by Fe2+/ascorbate in rat liver 
homogenate was found to be inhibited by the HAE in 
 
 
Fig. 1 — Superoxide radical scavenging activity. Values are
mean±SEM of three replicate experiments. % Scavenging activity
of HAE is statistically significant at P <0.05, compared to 
quercetin and gallic acid (standards) 
 
 
 
Fig. 2 — Hydroxyl radical scavenging activity. Values are
mean±SEM of three replicate experiments. % Scavenging activity
of HAE is statistically significant at P <0.05, compared to 
quercetin and gallic acid (standards) 
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a concentration-dependent manner and a considerable 
amount of lipid peroxidation inhibitory effect was 
observed by 62.13±0.18%, while quercetin and gallic 
acid inhibited by 72.12±0.12, and 70.23±0.11%, 
respectively, at 250 µg/mL (Fig. 3). Test results were 
considered statistically significant when compared to 
standard drugs (P <0.05). 
 
Acute toxicity study  
No sign and symptoms of acute toxicity and 
mortality up to 2000 mg/kg body weight dose were 
observed during the whole experimental period.  
The body weight and food consumption were  
normal compared to vehicle-treated rats. For further 
studies, the doses were fixed as 250 and 500 mg/kg  
body weight. The dosages were fixed judiciously 
considering the efficacy and toxicity levels of extracts 
as per OECD guidelines. 
 
Effect of HAE on OGT test in normal rats 
In OGT, HAE (250 and 500 mg/kg) showed 
significant (P <0.05) reduction of glucose load 
(plasma glucose level) as compared to normal control 
group. The metformin (5 mg/kg) treated group also 
showed significant (P <0.05) activity compared to the 
normal control group (Fig. 4). 
 
Effect of HAE on blood glucose levels in diabetic rats 
STZ-treated diabetic rats exhibited a significant 
increase in the levels of blood glucose in comparison 
to normal rats. After treatment with HAE, the blood 
glucose levels were significantly (P <0.05) reduced 
compared to the diabetic control rats at both the 
doses, viz. 250, 500 mg/kg. The metformin (5 mg/kg) 
treated rats also showed significant (P <0.05) 
reduction in plasma glucose level when compared to 
normal rats. Results of the effect of HAE on blood 
glucose levels in normal and diabetic rats are depicted 
in Table 1.  
 
 
 
Fig. 3 — Lipid peroxidation scavenging activity. Values are
mean±SEM of three replicate experiments. % Scavenging activity
of HAE is statistically significant at P <0.05, compared to 
quercetin and gallic acid (standards) 
 
 
 
Fig. 4 — OGT test. Values are mean±SEM of three replicate
experiments. Activities of HAE and metformin (metformin) are 
statistically significant at P <0.05, compared to normal control. 
Table 1 — Effect of HAE on blood glucose levels in normal and diabetic rats 
Group Days 
 0 day 7th day 14th day 21st day 
Normal control 
 
94.39±2.71 102.86±3.51 103.49±3.99 99.88±2.58 
Diabetic control 
STZ (55 mg/kg, i.p.) 
266.72±8.29 289.21±9.57 298.12±6.58 322.64±11.86 
Diabetic + HAE  
(250 mg/kg, p.o.) 
259.82±9.48 226.91±8.23* 159.84±6.56* 110.18±9.31* 
Diabetic + HAE  
(500/kg, p.o.) 
258.62± 8.38 225.72±7.43* 138.62±5.38* 103.29±8.09* 
Diabetic + Metformin 
(5 mg/kg, p.o.) 
264.56±7.26 170.66±8.95 116.89±9.04 76.99±8.63 
Values indicate mean ± SEM (n = 6); *P <0.05, compared with normal control values 
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Effect of HAE on body weight, plasma insulin and liver 
glycogen in diabetic rats 
Table 2 depicts the effect of HAE on body weight, 
levels of plasma insulin and liver glycogen in  
STZ-induced diabetic rats. In diabetic rats, the body 
weight, insulin level and glycogen content were 
significantly decreased. After 21 days of treatment 
with HAE at 250 or 500 mg/kg, the body weight was 
significantly (P <0.05) increased, insulin level and 
glycogen content were also significantly (P <0.05) 
increased as compared to diabetic rats. The activity of 
HAE was found less than that of metformin (5 mg/kg) 
treated group. 
 
Effect of HAE on lipid profile in diabetic rats 
The effect of HAE on lipid profile of diabetic rats 
is displayed in Table 3. In diabetic rats, the levels of 
TG, TC, and LDL were significantly increased and 
HDL level was significantly decreased. In HAE (250 
& 500 mg/kg) treated groups, the TG, TC and LDL 
levels activities were significantly (P <0.05) reduced 
and the HDL level was significantly (P <0.05) 
increased as compared to diabetic control rats, which 
is, in turn, comparable to metformin (5 mg/kg)  
treated group. 
 
Effect of HAE on SGOT, SGPT, ALKP, TPR and CRTN in 
diabetic rats 
There was a significant increase in activities  
of SGOT, SGPT and ALKP in diabetic rats.  
After treatment with HAE (250 and 500 mg/kg) the 
activities of SGOT, SGPT and ALKP activities  
were significantly (P <0.05) reduced as compared to 
diabetic control rats. A significant decrease in serum 
TPR level and a significant increase in CRTN level 
were observed in diabetic rats. After treatment with 
HAE at 250 or 500 mg/kg doses for 21 days, the TPR 
level was significantly increased (P <0.05) and CRTN 
level was significantly (P <0.05) decreased compared 
to diabetic control rats. Metformin (5 mg/kg) treated 
rats also showed significant effects on blood levels of 
SGOT, SGPT, ALKP, TPR and CRTN in diabetic rats 
(Table 4). 
 
Effect of HAE on liver enzymes and MDA 
Table 5 displays the activities of SOD, CAT, GSH 
and GPx in normal and diabetic rats. In STZ-treated 
diabetic rats, the activities of SOD, CAT, GSH and 
GPx were significantly increased. There was a 
significant (P <0.05) reduction in the activities of 
these antioxidant enzymes in diabetic rats as 
compared to normal rats. Metformin (5 mg/kg) also 
Table 2 — Effect of HAE on body weight, plasma insulin and liver glycogen in normal and diabetic rats 
Group Body weight in g Plasma insulin (µU/mL) Liver glycogen (mg/g tissue) 
 0 day 21st day   
Normal control 
 
200.50±2.84 205.38±11.49 15.31±3.62 72.14±2.23 
Diabetic control 
STZ (55 mg/kg, i.p.) 
205.67±4.88 130.38±7.27 6.23±6.45 32.18±2.25 
 Diabetic + HAE  
(250 mg/kg, p.o.) 
205.31±4.06 171.21±7.96 8.23±3.65* 54.20±4.14 
 Diabetic + HAE  
(500 mg/kg, p.o.) 
208.84±4.49 180.64±6.29 12.59±40 62.34±5.62 
Diabetic+ Metformin 
(5 mg/kg, p.o.) 
206.66±2.32 
 
192.59±8.30 
 
15.65±6.72 72.80±6.67 
Values indicate mean ± SEM (n = 6); *P <0.05, compared with normal control values 
 
Table 3 — Effect of HAE on lipid profile in normal and diabetic rats 
Groups TG (mg/dL) TC (mg/dL) HDL (mg/dL) LDL(mg/dL) 
Normal control 
 
86.89±7.26 152.20±6.56 38.29±2.14 95.32±4.92 
Diabetic control 
STZ (55 mg/kg, i.p.) 
210.43±6.84 270.83±14.96 30.61±2.60 199.33±15.67 
Diabetic + HAE  
(250 mg/kg, p.o.) 
164.38±7.86 190.71±9.51 31.79±4.41 156.82±7.49 
Diabetic + HAE  
(500 mg/kg, p.o.) 
144.84±6.23 181.29±8.37 36.95±2.34* 136.32±5.86 
Diabetic + Metformin 
(5 mg/kg, p.o.) 
115.29±3.79 146.59±11.15 54.69±3.28 78.89±6.74 
Values indicate mean ± SEM (n = 6); *P <0.05, compared with normal control values 
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showed significant (P <0.05) reduction of these 
enzymes. Increased levels of MDA, an indicator of 
LPO, in diabetic rats were significantly (P <0.05) 
reduced after treatment with HAE (250 or 500 mg/kg) 
as compared to the normal rats. 
 
Histopathological observations 
 
Effect of HAE on the pancreatic section in normal and diabetic 
rats 
Histopathological studies of STZ-treated diabetic 
rat’s pancreas (Plate 1) exhibited a reduction in the 
dimensions of islets, damaged β-cell population and 
extensive necrotic changes followed by fibrosis and 
atrophy (B). HAE (500 mg/kg) and metformin-treated 
rats restored the necrotic and fibrotic changes and also 
increased the number and increased the size of the 
islets (C). In the normal control group, normal acini 
and normal cellular population in the islets of 
Langerhans in the pancreas were observed (A). The 
changes in pancreas morphology in metformin treated 
group (D) are similar to HAE treated rats. 
 
Effect of HAE on the liver section in normal and diabetic rats 
Photomicrographs of STZ-treated diabetic rat’s 
liver (Plate 2) showed normal hepatic cells with well-
preserved cytoplasm, nucleus, nucleolus and central 
vein (a). In the case of diabetic rats, the normal 
lobular structure was preserved. The central vein was 
prominent and prominently congested. Focal areas of 
haemorrhage were also seen. Vacuolization and fatty 
change were evident. The portal tracts appeared 
normal (b). In diabetic treated group (HAE, 500 
mg/kg), the hepatocytes portal tracts and central veins 
appeared normal (c). HAE treated group is 
comparable with the metformin-treated group (d). 
 
Discussion  
C. brachiata leaves hydro-alcoholic extract did not 
exhibit toxicities up to a dose of 2000 mg/kg b.w. in 
experimental animals which indicated a high margin 
of safety of bioactive principles present in the extract. 
HAE treated rats lowered glucose level when 
compared to normal rats which indicated that the 
increased glucose tolerance in HAE treated rats was 
due to insulin secretion from β-cells and increased 
glucose utilization by the tissues18. The HAE treated 
group exhibited a significant reduction of fasting 
plasma glucose levels as compared to the diabetic 
control group. Administration of HAE to diabetic rats 
showed a significant reduction in the levels of blood 
glucose and an increase in the levels of serum  insulin.  
Table 4 — Effect of HAE on SGOT, SGPT, ALKP, TPR and CRTN in normal and diabetic rats 
Group SGOT  
(U/L) 
SGPT  
(U/L) 
ALKP  
(U/L) 
TPR 
(mg/dL) 
CRTN 
(mg/dL) 
Normal control 
 
49.78±6.69 46.89±6.23 116.61±4.98 8.89±0.46 0.436±0.026 
Diabetic control 
STZ (55 mg/kg, i.p.) 
102.80±8.43 88.39±4.59 320±8.95 4.62±0.92 0.826±0.037 
Diabetic + HAE  
(250 mg/kg, p.o) 
79.28±6.71* 69.83±7.42* 160.63±5.33 6.82±0.34* 0.628±0.042 
Diabetic + HAE  
(500 mg/kg, p.o.) 
71.32±7.85 64.82±6.28 144.31±9.13 8.20±0.54 0.573±0.056 
Diabetic + Metformin 
(5 mg/kg, p.o.) 
58.79±7.61 53.91±8.56 132±6.52 8.98±2.02 0.434±0.062 
Values indicate mean ± SEM (n = 6); *P <0.05, compared with normal control values 
 
Table 5 — Effect of HAE on SOD, CAT, GSH, GPx and MDA in normal and diabetic rats 
Treatment SOD  
(U/mg protein) 
CAT  
(U/mg protein) 
GSH  
(U/mg protein) 
GPx  
(U/mg protein) 
MDA (LPO) 
(U/mg protein) 
Normal control 
 
8.28±0.06 72.16±4.32 16.20±0.48 23.12±1.89 0.52±0.12 
Diabetic control 
STZ (55 mg/kg, i.p.) 
4.23±0.08 42.60±3.69 6.20±0.28 9.12±0.48 0.82±0.03 
Diabetic + HAE  
(250 mg/kg, p.o.) 
6.22±0.09 58.02±4.20 9.23±0.28* 12.28±0.44 0.72±0.06* 
Diabetic + HAE  
(500 mg/kg, p.o.) 
7.67±0.06 64.74±7.26 12.67±0.64 18.43±0.65 0.64±0.04 
Diabetic + Metformin 
(5 mg/kg, p.o.) 
8.51±0.05 69.86±3.64 15.20±1.20 20.34±0.82 0.50±0.10 
Values indicate mean±SEM (n = 6); *P <0.05, compared with normal control values 
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Plate 1 — Histology of pancreas of experimental rats after treatment with HAE, 500 mg/kg. a) Normal control, b) Diabetic control, c) 
Diabetic treated with HAE (500 mg/kg), and d) Diabetic treated with metformin 
 
 
 
Plate 2 — Histology of liver of experimental rats after treatment with HAE, 500 mg/kg. a) Normal control, b) Diabetic control, c) 
Diabetic treated with HAE (500 mg/kg), d) Diabetic treated with metformin 
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The possible mechanism by which HAE brought 
about its hypoglycemic action might be by improving 
glycaemic control mechanism and by increasing insulin 
secretion from regenerated β-cells of pancreas19. It was 
further supported by histopathological observations 
which clearly revealed the presence of shrinkage, 
necrosis and damaged β-cell population in the 
endocrine region of the pancreas in STZ-induced 
diabetic rats. Our finding is consistent with an earlier 
report by Irudayaraj and co-authors2. 
Diabetic rats treated with HAE showed an 
improvement in body weight in comparison to the 
diabetic control rats and standard metformin-treated 
rats, signifying the protective effect of HAE in 
controlling muscle wasting. Moreover, the ability of 
HAE to protect body weight loss might be the result 
of its ability to reduce hyperglycemia. The liver 
glycogen content was markedly reduced in diabetic 
animals, which was in proportion to insulin 
deficiency. Diabetic rats treated with HAE increased 
significantly the liver glycogen content as compared 
to diabetic control, which could be due to increased 
insulin secretion. The significant increase in the 
glycogen levels of the HAE treated diabetic animals 
might be because of the reactivation of the glycogen 
synthase system. 
Elevation of plasma lipid concentration in diabetes 
is well documented. The most common lipid 
abnormalities in diabetes are hypertriglyceridemia and 
hypercholesterolemia. The increase in serum TG and 
TC observed in untreated diabetic rats is in agreement 
with the findings of Shirwaikar et al.20. Under normal 
circumstances, insulin activates enzyme lipoprotein 
lipase and hydrolyses triglycerides. Insulin deficiency 
results in failure to activate the enzymes leading to 
hypertriglyceridemia. Diabetic rats treated with HAE 
significantly improved serum TG and TC. The 
significant control of the levels of serum lipids in the 
HAE treated diabetic rats might be attributed to 
improvements in insulin levels. Significant lowering 
of LDL cholesterol and raise in HDL cholesterol were 
observed in treated diabetic rats. The HAE extract-
treated animals showed a weight loss, which probably 
is due to the lipid-lowering activity of the extract or 
indirectly due to the influence on various lipid 
regulation systems. The lipid-lowering activity of the 
HAE may help in the prevention of diabetic 
complications like atherosclerosis and ischaemic 
conditions. 
An increase in the activities of SGOT, SGPT and 
ALP in plasma of diabetic rats might be mainly due to 
the leakage of these enzymes from the liver cytosol 
into the bloodstream which was an indicator of the 
hepatotoxic effect of STZ21. Treating diabetic rats 
with HAE reduced the activity of these enzymes 
compared to the diabetic control group. Reduction in 
plasma TPR was observed in diabetic rats. This might 
be due to the distinct metabolic renal alterations in the 
diabetic state, leading to a negative nitrogen balance, 
enhanced proteolysis and decreased protein synthesis. 
The plasma protein level was improved in diabetic 
rats after treatment with HAE. Diabetic rats showed a 
significantly increased level of CRTN, a reliable 
marker of renal dysfunction, in the serum. The 
significant reduction in the level of CRTN in HAE 
treated diabetic rats indicated that the HAE prevented 
the progression of renal damage in diabetic rats. 
In diabetes mellitus, high glucose level can 
inactivate antioxidant enzymes SOD, CAT, GSH and 
GPx by glycating these proteins thus producing 
induced oxidative stress, which in turn, causes lipid 
peroxidation. Furthermore, malonaldehyde (MDA) is 
one of the end products in the LPO process. LPO in 
the tissue homogenate was determined by measuring 
the amounts of MDA produced primarily22 SOD¸ 
CAT, GSH and GPx activities were increased to 
normal indicating the efficacy of HAE in attenuating 
the oxidative stress (OS) and eventual inhibition of 
LPO in diabetic liver. A decrease in MDA level 
indicated a reduced rate of LPO in HAE treated 
diabetes. 
Increasing evidence in both experimental and 
clinical studies suggest that OS plays a crucial role in 
the pathogenesis of both types (type 1 and type 2) of 
diabetes mellitus. Plant antioxidants play a vital role 
in the alleviation of diabetes. STZ produces oxygen 
radicals in the body, which cause pancreatic injury 
and could be responsible for increased blood sugar 
level in animals. Moreover, abnormally high levels of 
free radicals and the simultaneous decline of 
antioxidant defence mechanisms can lead to the 
development of insulin resistance23,24. In our study, a 
marked increase in the concentration of TBARS and 
MDA were observed in STZ induced diabetic rats 
indicating the LPO of tissues under OS. HAE 
significantly decreased TBARS levels as well as 
MDA in the liver of diabetic rats, indicating strong 
lipid peroxidation scavenging activity of HAE as an 
antioxidant agent. Superoxide directly initiates LPO 
and plays an important role in the formation of other 
ROS like hydroxyl radicals, which induce oxidative 
damage in lipids, proteins and DNA. Hydroxyl 
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radicals are more potent than superoxides, and HAE 
could effectively scavenge these radicals together with 
the inhibition of LPO, wherein it scavenged active 
oxygen species by preventing the propagation of free 
radical chain reaction as an antioxidant. The reducing 
property of HAE indicates it acts as electron donors, 
which reduce the oxidized intermediates of LPO 
process and subsequent reaction mechanism25-27. 
Studies28,29 suggest that high molecular weight phenolic 
compounds including plant flavonoids comprising 
hydroxyl group and aromatic ring serve as potent free 
radical scavengers. The phenolic compounds may 
suppress LPO through different chemical mechanisms, 
including free radical quenching, electron transfer, 
radical addition, or radical recombinations. It is now 
assumed that the antioxidant activity is responsible for 
the antidiabetic action of the HAE, and phenolic 
compounds and flavonoids present in the HAE may be 
involved in reducing underlying cellular OS and 
eventual hypoglycemic reactions. Kusirisin et al.30 
have shown that phenolic compounds possess free 
radical scavenging properties and hence reduce the 
oxidative stress associated with diabetes mellitus. 
Aromatic plants are especially rich in phenolic and 
flavonoid contents and have been widely used in 
traditional medicine as a treatment for many diseases 
including diabetes. In fact, it was found that traditional 
medicines used in human diabetes also have significant 
antioxidant activity. Plants rich in phenolics, flavonoids 
and related substances, have antioxidant activity due to 
their redox properties, and as their free radicals 
scavenging ability is facilitated by hydroxyl groups. It 
has been reported that antioxidant properties of plant-
derived phenolic compounds are brought about mainly 
via scavenging of superoxide anion radicals31,32. 
Literature reports33,34 also tell us plant flavonoids have 
antioxidant activity in vitro and also act as antioxidants 
in vivo. Abdelmoaty et al., (2010)35 studied that 
quercetin, a plant flavonoid with antioxidant properties, 
has antidiabetic efficacy in diabetic rats. Flavonoids 
suppress reactive oxygen formation, chelated trace 
elements involved in free-radical production, scavenge 
reactive species and also protect antioxidant defences 
and thus help in the prevention of diseases. 
 
Conclusion 
The findings of the present investigation justify  
the traditional use of C. brachiata (Lour.) Merill 
(Rhizophoraceae) leaves in ethnomedicine of northeast 
India for the treatment of diabetes. The antioxidant 
activity of C. brachiata leaves reported herein 
signifies the potential of the plant as a herbal 
antioxidant with a possible role in the prevention of 
oxidative stress-induced diabetes and associated 
disease complications. Studies are in progress in our 
laboratory to isolate bioactive principles from HAE 
extract of C. brachiata leaves and further exploration 
of biochemical mechanisms involved in antidiabetic 
action of isolated compounds. As this is the first 
report on the antioxidant activity of C. brachiata, 
thorough phytochemical analyses need to be executed 
in order to identify the possible antioxidant phenolic 
and flavonoid components responsible for antidiabetic 
activity. 
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